Fold Holdings, Inc. Class A Common Stock (FLD)vsMorgan Stanley (MS)
FLD
Fold Holdings, Inc. Class A Common Stock
$0.54
+3.73%
FINANCIAL SERVICES · Cap: $25.46M
MS
Morgan Stanley
$214.38
+0.81%
FINANCIAL SERVICES · Cap: $336.70B
Smart Verdict
WallStSmart Research — data-driven comparison
Morgan Stanley generates 275767% more annual revenue ($77.83B vs $28.21M). MS leads profitability with a 25.9% profit margin vs -258.6%. MS earns a higher WallStSmart Score of 75/100 (B).
FLD
Hold38
out of 100
Grade: F
MS
Strong Buy75
out of 100
Grade: B
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 1622.0% YoY
Mega-cap, among the largest globally
Strong operational efficiency at 41.6%
Earnings expanding 62.4% YoY
Keeps 26 of every $100 in revenue as profit
Attractively priced relative to earnings
Revenue surging 28.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -137.2% — below average capital efficiency
Revenue declined 25.5%
Expensive relative to growth rate
Negative free cash flow — burning cash
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : FLD
The strongest argument for FLD centers on Price/Book, EPS Growth.
Bull Case : MS
The strongest argument for MS centers on Market Cap, Operating Margin, EPS Growth. Profitability is solid with margins at 25.9% and operating margin at 41.6%. Revenue growth of 28.0% demonstrates continued momentum.
Bear Case : FLD
The primary concerns for FLD are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : MS
The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.75 is elevated, increasing financial risk.
Key Dynamics to Monitor
FLD profiles as a turnaround stock while MS is a growth play — different risk/reward profiles.
MS carries more volatility with a beta of 1.21 — expect wider price swings.
MS is growing revenue faster at 28.0% — sustainability is the question.
FLD generates stronger free cash flow (-10M), providing more financial flexibility.
Bottom Line
MS scores higher overall (75/100 vs 38/100), backed by strong 25.9% margins and 28.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fold Holdings, Inc. Class A Common Stock
FINANCIAL SERVICES · CAPITAL MARKETS · USA
Fold Holdings, Inc. (FLD) is an innovative biotechnology firm dedicated to the development of groundbreaking therapies for severe genetic and rare diseases, utilizing advanced research methodologies and proprietary technologies. With a promising product pipeline bolstered by strategic collaborations, the company is poised to capitalize on substantial market opportunities within the healthcare sector. Fold's steadfast focus on scientific excellence and patient-centered solutions underscores its potential as a significant investment prospect, offering the promise of long-term growth and enhanced shareholder value in an evolving industry landscape.
Visit Website →Morgan Stanley
FINANCIAL SERVICES · CAPITAL MARKETS · USA
Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.
Compare with Other CAPITAL MARKETS Stocks
Want to dig deeper into these stocks?